MA, H., D, D., R, S., A, D., JS, M., MJ, M., . . . CG, K. (2025). Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation. Blood advances, 9(10), 2553. https://doi.org/10.1182/bloodadvances.2024014879
Chicago Style (17th ed.) CitationMA, Hyder, et al. "Intermediate-dose Posttransplantation Cyclophosphamide for Myeloablative HLA-haploidentical Bone Marrow Transplantation." Blood Advances 9, no. 10 (2025): 2553. https://doi.org/10.1182/bloodadvances.2024014879.
MLA (9th ed.) CitationMA, Hyder, et al. "Intermediate-dose Posttransplantation Cyclophosphamide for Myeloablative HLA-haploidentical Bone Marrow Transplantation." Blood Advances, vol. 9, no. 10, 2025, p. 2553, https://doi.org/10.1182/bloodadvances.2024014879.